Prenetics Global Limited operates as an investment holding company specializing in diagnostics and genetic testing. Its core offerings include CircleDNA, a consumer genetic testing solution, and the Circle HealthPod, a rapid detection health monitoring system that enables users to perform point-of-care or at-home COVID-19 tests using nucleic acid amplification technology. The company's portfolio further comprises ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an accessible at-home blood testing kit; and Circle Medical, a diagnostic testing platform.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 18, 2026 | -$0.84 | -$0.53 | Beat |
| Jun 10, 2026 | -$1.02 | -$1.36 | Miss |
| Feb 18, 2026 | -$0.33 | -$1.77 | Miss |
| Nov 10, 2025 | -$0.55 | -$0.41 | Beat |
| Sep 12, 2025 | -$0.71 | -$0.82 | Miss |
| Jun 12, 2025 | -$0.80 | -$0.80 | Beat |